Evidence map›Paper›PMID 41544142›Full record

ArticlePLoS pathogens2026

Structural mapping of NTCP distinguishes its dual functionality as a hepatitis B virus receptor and bile acid transporter.

Kayo Matsuzawa, Toru Ekimoto, Chisa Kobayashi, Kaho Shionoya, Junki Mifune, Takeshi Morita, Junko S Takeuchi, Sam-Yong Park, Mitsunori Ikeguchi, Camille Sureau and 2 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kayo MatsuzawaDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Toru EkimotoComputational Life Science Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
Chisa KobayashiDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Kaho ShionoyaDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Junki MifuneDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Takeshi MoritaDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.
Junko S TakeuchiDepartment of Academic-Industrial Partnerships Promotion, Center for Clinical Sciences, Japan Institute for Health Security, Tokyo, Japan.
Sam-Yong ParkDrug Design Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
Mitsunori IkeguchiComputational Life Science Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan.
Camille SureauINSERM U1259, Université de Tours, Tours, France.
Atsushi KawaguchiDepartment of Infection Biology, Transborder Medical Research Center, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
Koichi WatashiDepartment of Drug Development, National Institute of Infectious Diseases, Japan Institute for Health Security, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4536-9966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sodium taurocholate cotransporting polypeptide (NTCP) is a hepatic transmembrane (TM) protein that functions both as a bile acid transporter and as a host receptor for hepatitis B and D viruses via the viral preS1 binding. The structural and mechanistical determinants for NTCP's dual functions remain largely undefined. In this study, using comprehensive structure-guided alanine-scanning mutagenesis based on the cryo-electron microscopy structure of the preS1/NTCP complex, we identified 13, 8 and 9 NTCP amino acid residues critical for viral infection, preS1 binding, and bile acid transport, respectively. Key residues overlappingly regulating viral receptor and transporter functions were located primarily at TM1 and TM8, whereas TM5 and outer-surface NTCP loops mediated viral receptor-specific activity. In addition to 8 amino acids key to preS1 binding, 5 residues likely acted at a post-preS1 binding step of infection. We further found naturally-occurring single nucleotide polymorphism-associated F274C/S NTCP variants abolished viral receptor function, via the potential conformational changes in bile acid tunnel and outer-surface hollow, as analyzed by molecular dynamics simulations. Our domain-specific structural-functional map of NTCP defines the mechanism how NTCP's dual functionality is separately regulated, and provides a framework for designing selective antiviral agents that preserve bile acid transport.

Indexed as

Hepatitis BHepatitis B virusOrganic Anion Transporters, Sodium-DependentReceptors, VirusSymportersCryoelectron MicroscopyHumansProtein PrecursorsOrganic Anion Transporters, Sodium-DependentProtein PrecursorsReceptors, Virussodium-bile acid cotransporterSymporters

Identifiers

PMID41544142
PMCPMC12810916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.